Search Results

Filter
  • 1-10 of  441 results for ""HYPOGLYCEMIC agents""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Metformin for preventing the progression of chronic kidney disease.

Subjects: Metformin*/Metformin*/Metformin*/therapeutic use ; Metformin*/Metformin*/Metformin*/adverse effects ; Randomized Controlled Trials as Topic*

  • Source: The Cochrane database of systematic reviews [Cochrane Database Syst Rev] 2024 Jun 04; Vol. 6. Cochrane AN: CD013414. Date of Electronic Publication: 2024 Jun 04.Publisher: Wiley Country of Publication: England NLM ID: 100909747 Publication Model: Electronic Cited Medium: Internet ISSN: 1469-493X

Record details

×
Academic Journal

Long-term effects of different hypoglycemic drugs on carotid intima-media thickness progression: a systematic review and network meta-analysis.

  • Authors : Lv Q; Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.; Yang Y

Subjects: Hypoglycemic Agents*/Hypoglycemic Agents*/Hypoglycemic Agents*/therapeutic use ; Carotid Intima-Media Thickness* ; Network Meta-Analysis*

  • Source: Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2024 May 31; Vol. 15, pp. 1403606. Date of Electronic Publication: 2024 May 31 (Print Publication: 2024).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101555782 Publication Model: eCollection Cited Medium: Print

Record details

×
Academic Journal

Pediatric Type 2 Diabetes: Not a Mini Version of Adult Type 2 Diabetes.

  • Authors : Savic Hitt TA; Division of Endocrinology & Diabetes, Department of Pediatrics, Children's Hospital of Philadelphia, 3500 Civic Center Boulevard, Buerger Building -12th Floor, Philadelphia, PA 19104, USA. Electronic address: .; Katz LEL

Subjects: Diabetes Complications*/Diabetes Complications*/Diabetes Complications*/diagnosis ; Diabetes Complications*/Diabetes Complications*/Diabetes Complications*/epidemiology ; Diabetes Complications*/Diabetes Complications*/Diabetes Complications*/therapy

  • Source: Endocrinology and metabolism clinics of North America [Endocrinol Metab Clin North Am] 2020 Dec; Vol. 49 (4), pp. 679-693. Date of Electronic Publication: 2020 Oct 14.Publisher: Elsevier Country of Publication: United States NLM ID: 8800104 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Metabolic outcomes of surgery in youth with type 2 diabetes.

  • Authors : Shah AS; Department of Pediatrics, Division of Pediatric Endocrinology, University of Cincinnati and Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States. Electronic address: .; Nadeau KJ

Subjects: Bariatric Surgery* ; Disease Progression* ; Outcome Assessment, Health Care*

  • Source: Seminars in pediatric surgery [Semin Pediatr Surg] 2020 Feb; Vol. 29 (1), pp. 150893. Date of Electronic Publication: 2020 Jan 25.Publisher: W.B. Saunders Country of Publication: United States NLM ID: 9216162 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Peripheral Biomarkers of Parkinson's Disease Progression and Pioglitazone Effects.

Subjects: Disease Progression* ; Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/blood ; Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/drug therapy

  • Source: Journal of Parkinson's disease [J Parkinsons Dis] 2015; Vol. 5 (4), pp. 731-6.Publisher: IOS Press Country of Publication: Netherlands NLM ID: 101567362 Publication Model: Print Cited Medium: Internet ISSN: 1877-718X

Record details

×
Academic Journal

Impact of empagliflozin on subclinical left ventricular dysfunctions and on the mechanisms involved in myocardial disease progression in type 2 diabetes: rationale and design of the EMPA-HEART trial.

  • Authors : Natali A; Department of Clinical and Experimental Medicine, Pisa University, Via Savi 27, 56100, Pisa, Italy.; Nesti L

Subjects: Disease Progression*; Benzhydryl Compounds/Benzhydryl Compounds/Benzhydryl Compounds/*therapeutic use ; Cardiomyopathies/Cardiomyopathies/Cardiomyopathies/*drug therapy

  • Source: Cardiovascular diabetology [Cardiovasc Diabetol] 2017 Oct 12; Vol. 16 (1), pp. 130. Date of Electronic Publication: 2017 Oct 12.Publisher: BioMed Central Country of Publication: England NLM ID: 101147637 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2840

Record details

×
Academic Journal

Effect of insulin versus triple oral therapy on the progression of hepatic steatosis in type 2 diabetes.

  • Authors : Lingvay I; Division of Endocrinology, University of Texas Southwestern Medical Center, Dallas, TX 75390-8857, USA. ; Roe ED

Subjects: Disease Progression*; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*complications ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy

  • Source: Journal of investigative medicine : the official publication of the American Federation for Clinical Research [J Investig Med] 2012 Oct; Vol. 60 (7), pp. 1059-63.Publisher: SAGE Publications Country of Publication: England NLM ID: 9501229 Publication Model: Print Cited Medium: Internet ISSN: 1708-8267

Record details

×
Academic Journal

Predictive factors for change of diabetes mellitus status after pancreatectomy in preoperative diabetic and nondiabetic patients.

  • Authors : Hirata K; Department of Surgical Oncology, Graduate School of Medicine, Osaka City University, 1-4-3 Asahimachi, Abeno-ku, Osaka, 545-8585, Japan.; Nakata B

Subjects: Disease Progression*; Biliary Tract Neoplasms/Biliary Tract Neoplasms/Biliary Tract Neoplasms/*complications ; Diabetes Mellitus/Diabetes Mellitus/Diabetes Mellitus/*drug therapy

  • Source: Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract [J Gastrointest Surg] 2014 Sep; Vol. 18 (9), pp. 1597-603. Date of Electronic Publisher: Elsevier B.V Country of Publication: United States NLM ID: 9706084 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

New therapies for diabetes.

  • Authors : Green DE; Division of Endocrinology, Mount Sinai School of Medicine, New York, New York 10029, USA.

Subjects: Disease Progression* ; Glucagon-Like Peptide 1*/Glucagon-Like Peptide 1*/Glucagon-Like Peptide 1*/analogs & derivatives ; Glucagon-Like Peptide 1*/Glucagon-Like Peptide 1*/Glucagon-Like Peptide 1*/therapeutic use

  • Source: Clinical cornerstone [Clin Cornerstone] 2007; Vol. 8 (2), pp. 58-63; discussion 64-5.Publisher: Excerpta Medica Country of Publication: United States NLM ID: 9816002 Publication Model: Print Cited Medium: Print ISSN: 1098-3597

Record details

×
Academic Journal

Preventing diabetes complications.

Subjects: DISEASE risk factors; LIPID analysis; DIABETES complications

  • Source: Internal Medicine Journal; Aug2024, Vol. 54 Issue 8, p1264-1274, 11p

Record details

×
  • 1-10 of  441 results for ""HYPOGLYCEMIC agents""